Certara, Inc. (CERT)
Nasdaq: CERT · Services-Prepackaged Software · Radnor, PA · filing with the SEC since 2020
Grade5.2
◀ Past 5.3● Present 5.3▶ Future 5.1
Who owns Certara, Inc.
As filed with the SECHolders of 5% or more
2
Terry M. Mullen holds 22.6% of Common Stock, par value $0.01 per share, as its SCHEDULE 13D/A filed Apr 14, 2025 says.
Directors and officers
17
report now, of 33 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Terry M. Mullen
SCHEDULE 13D/A · filed Apr 14, 2025 · Common Stock, par value $0.01 per share
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock
Deerfield Mgmt, L.P.
SCHEDULE 13G/A · filed Nov 25, 2025 · Common Stock · reported falling below 5%, from 6.29% in Nov 13, 2025
Dimensional Fund Advisors LP
SCHEDULE 13G/A · filed Jul 14, 2026 · Common Stock · reported falling below 5%, from 5.2% in Oct 9, 2025
Wasatch Advisors LP
SCHEDULE 13G/A · filed Apr 6, 2026 · COM · reported falling below 5%, from 3.3% in Apr 6, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
Mubadala Investment Company PJSC
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%
What CERT reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Chemaxon, Kft.
A company bought · acquisition · Sep 2024 · owns, named in the 10-K filed Feb 26, 2026
Applied Biomath
A company bought · acquisition · Nov 2023 · owns, named in the 10-K filed Feb 26, 2026
Formedix
A company bought · acquisition · Sep 2023 · owns, named in the 10-K filed Feb 26, 2026
Drug Interaction Solutions University of Washington (DIDB)
A company bought · acquisition · Jun 2023 · owns, named in the 10-K filed Feb 26, 2026
DIDB, Formedix, and ABM
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
43 subsidiaries in 20 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 43 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Feehery William F | CHIEF EXECUTIVE OFFICER | 0 | $0 | 0 | 1 | $200,000 |